
    
      Eligible subjects will be treated with the Pipeline™ Flex Embolization Device with Shield
      Technology™.

      Subjects will undergo standard of care follow-up visits. Data generated per standard of care
      will be collected for 1 year beyond the index procedure.

      This clinical trial information was submitted voluntarily under the applicable law and,
      therefore, certain submission deadlines may not apply. (That is, clinical trial information
      for this applicable clinical trial was submitted under section 402 (j)(4)(A) of the Public
      Health Service Act and 42 CFR 11.60 and is not subject to the deadlines established by
      sections 402 (j)(2) and (3) of the Public Health Service Act or 42 CFR 11.24 and 11.44.)
    
  